Medicine
Scopolamine 1 mg/3 days transdermal patch
Scopolamine 1 mg/3 days transdermal patch is a generic prescription medicine for transdermal use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Store pouch(es) in an upright position.
Key facts
- Active ingredient (INN)
- Scopolamine
- Brand
- Sold under the generic name
- Strength
- 1 mg/3 days
- Dosage form
- Transdermal patch
- Route
- Transdermal
- Packs
- 10 pouches, 4 pouches, 24 pouches and 20 more
- Manufacturers
- Zydus LifesciencesIndiaBryant Ranch PrepackAmneal Pharmaceuticals NYMylan PharmaceuticalsRhodes PharmaceuticalsA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Store pouch(es) in an upright position.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD01 Scopolamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 June 2019
- Identifiers
- RxCUI 226552DailyMed set ID 163accb7-45e6-4d97-844d-72b606677008, a472ee74-76a7-470f-8564-9018940a82e8, b24c2315-c947-4ad2-89fe-8dc0c45e221b +8NDC 0378-6470, 72162-2453, 50090-5349 +8Application ANDA203753, ANDA215329, ANDA217893 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 70710-1846-2 | Zydus LifesciencesIndia | 5 September 2024 |
| 4 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 70710-1846-4 | Zydus LifesciencesIndia | 5 September 2024 |
| 24 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 70710-1846-7 | Zydus LifesciencesIndia | 5 September 2024 |
| 10 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 70771-1787-2 | Zydus LifesciencesIndia | 5 September 2024 |
| 4 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 70771-1787-4 | Zydus LifesciencesIndia | 5 September 2024 |
| 24 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 70771-1787-7 | Zydus LifesciencesIndia | 5 September 2024 |
| 10 patch in 1 carton / 3 d in 1 patch | 69238-1662-2 | Amneal Pharmaceuticals NY | 11 June 2025 |
| 24 patch in 1 carton / 3 d in 1 patch | 69238-1662-4 | Amneal Pharmaceuticals NY | 11 June 2025 |
| 4 patch in 1 carton / 3 d in 1 patch | 69238-1662-9 | Amneal Pharmaceuticals NY | 11 June 2025 |
| 24 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 0378-6470-44 | Mylan Pharmaceuticals | 19 June 2019 |
| 10 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 0378-6470-97 | Mylan Pharmaceuticals | 19 June 2019 |
| 4 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch | 0378-6470-99 | Mylan Pharmaceuticals | 19 June 2019 |
| 10 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 42858-150-14 | Rhodes Pharmaceuticals | 1 November 2024 |
| 4 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 42858-150-40 | Rhodes Pharmaceuticals | 1 November 2024 |
| 24 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 42858-150-70 | Rhodes Pharmaceuticals | 1 November 2024 |
| 4 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 71335-3013-1 | Bryant Ranch Prepack | 18 November 2025 |
| 10 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 71335-3014-1 | Bryant Ranch Prepack | 18 November 2025 |
| 24 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 71335-3015-1 | Bryant Ranch Prepack | 18 November 2025 |
| 4 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 72162-2453-2 | Bryant Ranch Prepack | 28 January 2025 |
| 10 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 72162-2453-4 | Bryant Ranch Prepack | 28 January 2025 |
| 24 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 72162-2453-7 | Bryant Ranch Prepack | 28 January 2025 |
| 4 pouch in 1 carton / 1 d in 1 pouch | 50090-5349-0 | A-S Medication Solutions | 9 November 2020 |
| 4 pouch in 1 carton / 1 d in 1 pouch | 50090-8154-0 | A-S Medication Solutions | 13 October 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 December 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Scopolamine 1 mg/3 days transdermal patch.
Other strengths and forms of Scopolamine
Clinical summary
Scopolamine is an anticholinergic indicated in adults for the prevention of nausea and vomiting associated with motion sickness, among other approved uses. It is available as transdermal patches and transdermal systems. MedsAcross supplies Scopolamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ScopolamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Transderm Scop prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Scopolamine 1 mg/3 days transdermal patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.